Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.98 USD | -6.37% | +11.92% | +94.77% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.77% | 331M | |
+32.76% | 50.85B | |
+0.11% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.95% | 26.11B | |
-22.13% | 19.13B | |
+8.11% | 13.05B | |
+27.57% | 12.16B | |
+24.59% | 12.08B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Insider Trends: Insider at Inovio Pharmaceutical Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact